Hydroxylation of the NOTCH1 intracellular domain regulates Notch signaling dynamics

Cell Death Dis. 2022 Jul 12;13(7):600. doi: 10.1038/s41419-022-05052-9.

Abstract

Notch signaling plays a pivotal role in the development and, when dysregulated, it contributes to tumorigenesis. The amplitude and duration of the Notch response depend on the posttranslational modifications (PTMs) of the activated NOTCH receptor - the NOTCH intracellular domain (NICD). In normoxic conditions, the hydroxylase FIH (factor inhibiting HIF) catalyzes the hydroxylation of two asparagine residues of the NICD. Here, we investigate how Notch-dependent gene transcription is regulated by hypoxia in progenitor T cells. We show that the majority of Notch target genes are downregulated upon hypoxia. Using a hydroxyl-specific NOTCH1 antibody we demonstrate that FIH-mediated NICD1 hydroxylation is reduced upon hypoxia or treatment with the hydroxylase inhibitor dimethyloxalylglycine (DMOG). We find that a hydroxylation-resistant NICD1 mutant is functionally impaired and more ubiquitinated. Interestingly, we also observe that the NICD1-deubiquitinating enzyme USP10 is downregulated upon hypoxia. Moreover, the interaction between the hydroxylation-defective NICD1 mutant and USP10 is significantly reduced compared to the NICD1 wild-type counterpart. Together, our data suggest that FIH hydroxylates NICD1 in normoxic conditions, leading to the recruitment of USP10 and subsequent NICD1 deubiquitination and stabilization. In hypoxia, this regulatory loop is disrupted, causing a dampened Notch response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Hypoxia
  • Humans
  • Hydroxylation
  • Mixed Function Oxygenases / metabolism
  • Receptor, Notch1* / metabolism
  • Signal Transduction
  • T-Lymphocytes / metabolism
  • Ubiquitin Thiolesterase / metabolism

Substances

  • NOTCH1 protein, human
  • Receptor, Notch1
  • USP10 protein, human
  • Mixed Function Oxygenases
  • Ubiquitin Thiolesterase